Text Size

Dedicated to scientific advancement and pioneering discoveries in ophthalmology

As a specialist with over 130 years of expertise, Santen is committed to continually investigating the latest in science and innovation to deliver the best vision experience.

About Publications Plus

Latest Publications

Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease – a randomized controlled trial

Konstas A.-G., Boboridis K. G., Athanasopoulos G. P., Haidich A.-B., Voudouragkaki I. C., Pagkalidou E., Katsanos A., Katz L. J.

Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review

Daull P., Garrigue J.-S., Liang H., Baudouin C.

Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial

Yoshida T.; Takagi Y.; Igarashi-Yokoi T.; Ohno-Matsui K.

Start a conversation to collaborate with us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022